David Macdonald from Truist Financial set a price target of $170 for NASDAQ:ENSG, indicating a potential increase of about 11.42%.
The company’s third-quarter results showed adjusted EPS below expectations, leading to a narrowed full-year 2024 EPS guidance.
Despite recent financial challenges, analysts have raised their forecasts for ENSG, reflecting confidence in its long-term growth prospects.
The Ensign Group, Inc. (NASDAQ:ENSG) is a prominent player in the healthcare sector, specializing in skilled nursing and rehabilitative care services. The company operates a network of facilities across the United States, providing essential services to a growing aging population. In a competitive landscape, Ensign Group stands out with its focus on quality care and strategic acquisitions.
On October 28, 2024, David Macdonald from Truist Financial set a price target of $170 for ENSG. At that time, the stock was priced at $152.57, suggesting a potential increase of about 11.42%. Despite recent financial challenges, this optimistic outlook reflects confidence in the company’s long-term growth prospects.
The Ensign Group recently announced its third-quarter results, which showed adjusted earnings per share (EPS) below expectations. This led to a narrowing of the full-year 2024 EPS guidance. Despite these setbacks, analysts have raised their forecasts for the company, indicating a belief in its ability to overcome short-term hurdles.
Currently, ENSG is trading at $152.79 on the NASDAQ, experiencing a slight decrease of 0.0229%, or $0.035. The stock’s trading range today has been between $152.57 and $156.07, with the latter being its highest price over the past year. The lowest price for the year was $94.56, highlighting significant growth over the period.
The company’s market capitalization is approximately $8.75 billion, with a trading volume of 175,659 shares. This substantial market cap underscores Ensign Group’s position as a key player in the healthcare industry, with investors closely watching its performance and future developments.